In a series of firsts for Jiangsu Province, Nanjing Children's Hospital successfully completed three advanced pediatric procedures using the SHURUI® single-port robotic system: pyeloplasty, ovarian cystectomy, and ureteral reimplantation in complex kidney anomalies.
Led by Prof. Yunfei Guo, the team used SHURUI®’s snake-like instruments through a single 2 cm umbilical incision to navigate delicate anatomy with precision and minimal trauma. In all cases, intraoperative bleeding was under 10 ml, and organ function was preserved.
With 3D magnified vision and tremor-free 360° articulation, the system enables fine dissection and reconstruction in tight pediatric spaces—greatly reducing the risk of postoperative complications and supporting faster, more complete recovery.
As of February 2025, over 10 such procedures have been completed, marking a new era of precision pediatric surgery in China. Nanjing Children’s Hospital is committed to expanding the clinical reach of robotic innovation to deliver safer, faster recovery to young patients.
.png)
.png)
.png)
Important Notes
The Single-port Endoscopic Surgical System (SR-ENS-600), developed and produced by Beijing Surgerii Robotics Company Limited, has been approved by the National Medical Products Administration (NMPA) in China for urology and gynecology laparoscopic surgeries. Surgeons who wish to learn the surgical operations of the SHURUI robot should contact Beijing Surgerii Robotics Co., Ltd. to participate in the official training program. Patients who want to participate in the registered clinical trials of the SHURUI robot should contact the official cooperative hospitals of Surgerii and consult with surgeons to determine their suitability for surgery with the SHURUI robot. Both surgeons and patients should carefully understand all information regarding the performance of surgeries by the SHURUI robot and its potential risks.
Beijing Surgerii Robotics Co., Ltd. owns Surgerii®, SHURUI®, and other
trademarks and may not be used without permission.
